EP1536834A4 - DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES

76 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17
Sheet 18
Sheet 19
Sheet 20
Sheet 21
Sheet 22
Sheet 23
Sheet 24
Sheet 25
Sheet 26
Sheet 27
Sheet 28
Sheet 29
Sheet 30
Sheet 31
Sheet 32
Sheet 33
Sheet 34
Sheet 35
Sheet 36
Sheet 37
Sheet 38
Sheet 39
Sheet 40
Sheet 41
Sheet 42
Sheet 43
Sheet 44
Sheet 45
Sheet 46
Sheet 47
Sheet 48
Sheet 49
Sheet 50
Sheet 51
Sheet 52
Sheet 53
Sheet 54
Sheet 55
Sheet 56
Sheet 57
Sheet 58
Sheet 59
Sheet 60
Sheet 61
Sheet 62
Sheet 63
Sheet 64
Sheet 65
Sheet 66
Sheet 67
Sheet 68
Sheet 69
Sheet 70
Sheet 71
Sheet 72
Sheet 73
Sheet 74
Sheet 75
Sheet 76

Every citation, both waysCites: the store holds 4 of 5

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO9311159A1	Cites	World Intellectual Property Organization (WIPO)	X	Search report	1-39
WO9535376A2	Cites	World Intellectual Property Organization (WIPO)	X	Search report	1-39
WO9535376A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
WO9311159A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
CLARK-LEWIS I ET AL: "STRUCTURAL REQUIREMENTS FOR INTERLEUKIN-8 FUNCTION IDENTIFIED BY DESIGN OF ANALOGS AND CXC CHEMOKINE HYBRIDS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 269, no. 23, 10 June 1994 (1994-06-10), pages 16075 - 16081, XP001030753, ISSN: 0021-9258	Non-patent	–	–	Search report	–

107 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims9

Priority claims
Document	Office	Kind	Date
243795	United States of America	–	2002-09-13
24379502	United States of America	A	2002-09-13
24379502	United States of America	A	2002-09-13
0328745	United States of America	W	2003-09-11
0328745	United States of America	W	2003-09-11
243795	–	–	–
US20020243795	–	–	–
US2003028745	–	–	–
WO2003US28745	–	–	–

Members107

Family members, oldest first
Document	Office	Kind
CA2226391A1	Canada	A1	1999-09-13
CA2322764A1	Canada	A1	1999-09-23
WO9947158A2	World Intellectual Property Organization (WIPO)	A2	1999-09-23
AU2821699A	Australia	A	1999-10-11
WO9947158A3	World Intellectual Property Organization (WIPO)	A3	1999-11-25
CA2245224A1	Canada	A1	2000-02-14
WO0009152A1	World Intellectual Property Organization (WIPO)	A1	2000-02-24
AU5274499A	Australia	A	2000-03-06
EP1061944A2	European Patent Office (EPO)	A2	2000-12-27
CA2305036A1	Canada	A1	2001-10-12
CA2335109A1	Canada	A1	2001-10-12
CA2405907A1	Canada	A1	2001-10-18
WO0176615A2	World Intellectual Property Organization (WIPO)	A2	2001-10-18
AU5208101A	Australia	A	2001-10-23
CA2305787A1	Canada	A1	2001-11-09
CA2408319A1	Canada	A1	2001-11-15
WO0185196A2	World Intellectual Property Organization (WIPO)	A2	2001-11-15
AU5811001A	Australia	A	2001-11-20
WO0176615A3	World Intellectual Property Organization (WIPO)	A3	2002-02-28
WO0185196A3	World Intellectual Property Organization (WIPO)	A3	2002-02-28
JP2002506830A	Japan	A	2002-03-05
US2002156034A1	United States of America	A1	2002-10-24
US2002165123A1	United States of America	A1	2002-11-07
EP1276493A2	European Patent Office (EPO)	A2	2003-01-22
EP1286684A2	European Patent Office (EPO)	A2	2003-03-05
AU762472B2	Australia	B2	2003-06-26
BR0110049A	Brazil	A	2003-07-01
US2003148940A1	United States of America	A1	2003-08-07
JP2003530355A	Japan	A	2003-10-14
JP2003532683A	Japan	A	2003-11-05
EP1061944B1	European Patent Office (EPO)	B1	2004-01-28
AT258444T	Austria	T	2004-02-15
ATE258444T1	Austria	T1	2004-02-15
DE69914463D1	Germany	D1	2004-03-04
CA2498723A1	Canada	A1	2004-03-25
WO2004024088A2	World Intellectual Property Organization (WIPO)	A2	2004-03-25
EP1286684B1	European Patent Office (EPO)	B1	2004-04-28
AU2003279715A1	Australia	A1	2004-04-30
AT265219T	Austria	T	2004-05-15
ATE265219T1	Austria	T1	2004-05-15
DE60103052D1	Germany	D1	2004-06-03
EP1276493B1	European Patent Office (EPO)	B1	2004-09-29
US2004197303A1	United States of America	A1	2004-10-07
AT277628T	Austria	T	2004-10-15
ATE277628T1	Austria	T1	2004-10-15
DE60106002D1	Germany	D1	2004-11-04
DE69914463T2	Germany	T2	2004-11-11
AU2001252081B2	Australia	B2	2004-12-23
WO2004024088A3	World Intellectual Property Organization (WIPO)	A3	2005-02-24
DE60103052T2	Germany	T2	2005-03-03
US2005059584A1	United States of America	A1	2005-03-17
US6875738B1	United States of America	B1	2005-04-05
AU2001252081B9	Australia	B9	2005-05-05
EP1536834A2	European Patent Office (EPO)	A2	2005-06-08
BR0314212A	Brazil	A	2005-07-19
US2005164935A1	United States of America	A1	2005-07-28
US6946445B1	United States of America	B1	2005-09-20
US2005265969A1	United States of America	A1	2005-12-01
JP2005539063A	Japan	A	2005-12-22
US2006014682A1	United States of America	A1	2006-01-19
DE60106002T2	Germany	T2	2006-02-02
CA2515158A1	Canada	A1	2006-02-28
CN1742997A	China	A	2006-03-08
AU2005205737A1	Australia	A1	2006-03-16
EP1642588A2	European Patent Office (EPO)	A2	2006-04-05
JP2006117633A	Japan	A	2006-05-11
BRPI0504758A	Brazil	A	2006-05-16
EP1642588A3	European Patent Office (EPO)	A3	2006-05-31
US7091310B2	United States of America	B2	2006-08-15
AU2001258110B2	Australia	B2	2006-10-19
US2006233748A1	United States of America	A1	2006-10-19
US2006252687A1	United States of America	A1	2006-11-09
AU2006252077A1	Australia	A1	2007-01-11
AU2006252080A1	Australia	A1	2007-01-11
US2007066523A1	United States of America	A1	2007-03-22
JP2007106768A	Japan	A	2007-04-26
US2007116669A1	United States of America	A1	2007-05-24
US2007160574A1	United States of America	A1	2007-07-12
WO2007079460A2	World Intellectual Property Organization (WIPO)	A2	2007-07-12
WO2007079460A3	World Intellectual Property Organization (WIPO)	A3	2007-09-13
EP1834961A2	European Patent Office (EPO)	A2	2007-09-19
US2007225216A1	United States of America	A1	2007-09-27
EP1536834A4This record	European Patent Office (EPO)	A4	2007-11-07
US2007275892A9	United States of America	A9	2007-11-29
WO2007138382A2	World Intellectual Property Organization (WIPO)	A2	2007-12-06
EP1882698A1	European Patent Office (EPO)	A1	2008-01-30
JP2008031143A	Japan	A	2008-02-14
BR0314212C1	Brazil	C1	2008-03-11
US7354899B2	United States of America	B2	2008-04-08
CA2564924A1	Canada	A1	2008-04-30
US7368425B2	United States of America	B2	2008-05-06
US7378098B2	United States of America	B2	2008-05-27
EP1834961A3	European Patent Office (EPO)	A3	2008-06-11
CN101200502A	China	A	2008-06-18
US7423011B2	United States of America	B2	2008-09-09
US7435718B2	United States of America	B2	2008-10-14
WO2007138382A3	World Intellectual Property Organization (WIPO)	A3	2008-11-06
US2008318855A1	United States of America	A1	2008-12-25
US2009098091A1	United States of America	A1	2009-04-16
JP2009143942A	Japan	A	2009-07-02

Showing 100 of 107

8 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2009-09-23	Application deemed to be withdrawnWithdrawn18D	18D
2009-08-21	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA	STAA
2007-11-07	Supplementary search report drawn up and despatchedA4	A4
2006-01-04	Request for extension of the european patent (deleted)DAX	DAX
2005-06-08	Request for examination filed17P	17P
2005-06-08	Designated contracting statesAK	AK
2005-06-08	Request for extension of the european patentAX	AX
2005-04-22	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI

Numbers

Publication: 1536834
Publication, DOCDB: 1536834
Publication, EPODOC: EP1536834
Application: 3773052
Application, DOCDB: 03773052
Application, EPODOC: EP20030773052

Titles3

German: ENTWURF VON CHEMOKIN-ANALOGA ZUR BEHANDLUNG VON ERKRANKUNGEN DES MENSCHEN
English: DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
French: CONCEPTION D'ANALOGUES DE CHIMIOKINES PERMETTANT DE TRAITER DES MALADIES HUMAINES

Classification

CPC, 12: C07K14/4718
A61K38/00
C07K14/523
C07K14/5421
A61P29/00
A61P3/14
A61P31/00
A61P35/00
A61P37/02
A61P43/00
A61P7/00
A61P9/00
Filled: the office’s first classification
IPC, 20: A01N37 18
A61K
A61K38 00
A61K38 19
A61K45 00
A61K49 00
A61P9 00
A61P29 00
C12P21 02
A61P31 00
A61P35 00
A61P37 02
A61P43 00
C07K7 06
C07K7 08
C07K14 47
C07K14 52
C07K14 54
C12P21 06
G01N33 53

Designated states1

Contracting states, 1: Türkiye

Design of chemokine analogs for the treatment of human diseases

Abstract

Term